Quantcast
Investor's Business Daily investors.com 08 Nov, 2023 19:00 am

Eli Lilly Wins FDA Approval For Highly Anticipated Weight-Loss Drug

Eli Lilly Wins FDA Approval For Highly Anticipated Weight-Loss Drug
The FDA approved a highly anticipated weight-loss drug from Eli Lilly on Wednesday. Eli Lilly stock rose less than 2% after the release.
Read full story at investors.com